Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2022-05-12 | 2022-05-19 | 160451 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-12 | 2023-07-06 | 160457 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-05-19 | 2022-05-21 | 160986 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2022-05-19 | 2022-05-21 | 160989 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-05-19 | 2022-06-04 | 160997 |
| TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-05-19 | 2022-08-19 | 161000 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-05-19 | 2022-12-22 | 161003 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-05-19 | 2022-08-09 | 161006 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-19 | 2023-07-06 | 161009 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-06-03 | 2022-07-20 | 161931 |
| TEVA-CINACALCET | 90MG | TABLET | Resolved | 2022-06-03 | 2022-07-01 | 161937 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-06-03 | 2022-08-19 | 161949 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161952 |
| TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2022-06-03 | 2022-08-09 | 161955 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-06-03 | 2022-08-16 | 161958 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-06-03 | 2022-08-16 | 161961 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161964 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2022-06-03 | 2024-02-06 | 161973 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161976 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |